Concentrix CEO Caldwell reports RSU share vesting

Concentrix Corp President and CEO Christopher A. Caldwell reported routine equity compensation activity involving company common stock.

Rhea-AI Filing Summary

Concentrix Corp President and CEO Christopher A. Caldwell reported routine equity compensation activity involving company common stock. On January 28, 2026, he acquired 2,855 shares of common stock at $0 per share upon the vesting of restricted stock units granted under the 2020 Stock Incentive Plan and tied to performance metrics over a three-year period ending November 30, 2025.

On the same date, 1,210 shares were withheld at a price of $36.32 per share, a transaction coded as "F," typically reflecting shares surrendered to cover tax obligations. After these transactions, Caldwell directly owned 361,075 shares of Concentrix common stock.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Caldwell Christopher A

Role President and CEO

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	2,855	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	1,210	$36.32	$44K

Holdings After Transaction: Common Stock — 361,075 shares (Direct)

Footnotes (1)

1. F1. Represents shares issued upon the vesting of restricted stock units awarded under the 2020 Stock Incentive Plan on January 27, 2023, subject to the satisfaction of performance metrics measured over a three-year period ending November 30, 2025.

FAQ

What insider activity did Concentrix (CNXC) report for CEO Christopher Caldwell?

Concentrix reported that CEO Christopher A. Caldwell received 2,855 common shares from vesting restricted stock units and had 1,210 shares withheld, with both transactions dated January 28, 2026. Following these events, he directly owned 361,075 Concentrix common shares.

How many Concentrix (CNXC) shares did the CEO acquire in the latest Form 4?

Christopher A. Caldwell acquired 2,855 Concentrix common shares at $0 per share. These shares were issued upon vesting of restricted stock units granted under the 2020 Stock Incentive Plan, contingent on performance metrics measured through November 30, 2025.

Why were 1,210 Concentrix (CNXC) shares reported with code "F" on the Form 4?

The 1,210 Concentrix shares reported with transaction code "F" were disposed of at $36.32 per share. Code "F" generally indicates shares withheld to satisfy tax obligations arising from equity awards, occurring here in connection with the same January 28, 2026 vesting event.

What is Christopher Caldwell’s Concentrix (CNXC) share ownership after these transactions?

After the reported transactions, Christopher A. Caldwell directly owned 361,075 Concentrix common shares. This figure reflects the net result of 2,855 shares received from vested restricted stock units and 1,210 shares withheld in the tax-related transaction on January 28, 2026.

What performance conditions were tied to the Concentrix RSUs that vested for the CEO?

The vested shares came from restricted stock units awarded on January 27, 2023 under the 2020 Stock Incentive Plan. These RSUs were subject to performance metrics measured over a three-year period ending November 30, 2025, and vested when those performance conditions were satisfied.

What roles does Christopher Caldwell hold at Concentrix (CNXC) according to the filing?

Christopher A. Caldwell is identified as both a director and an officer of Concentrix, serving as President and CEO. The Form 4 indicates he is not a 10% owner, and the reported holdings reflect his direct beneficial ownership of company common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/30/2026 - 04:12 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Caldwell Christopher A

(Last) (First) (Middle)

39899 BALENTINE DRIVE

SUITE 235

(Street)

NEWARK CA 94560

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Concentrix Corp [ CNXC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

3. Date of Earliest Transaction (Month/Day/Year)
01/28/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/28/2026		A		2,855(1)	A	$0	362,285	D
Common Stock	01/28/2026		F		1,210	D	$36.32	361,075	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares issued upon the vesting of restricted stock units awarded under the 2020 Stock Incentive Plan on January 27, 2023, subject to the satisfaction of performance metrics measured over a three-year period ending November 30, 2025.

Remarks:

	/s/ Andrew A. Farwig, Attorney-in-Fact	01/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.